Showing 41 - 60 results of 5,085 for search '"cardiovascular"', query time: 0.08s Refine Results
  1. 41
  2. 42

    The Quality of Veterans Healthcare Administration Cardiovascular Care by D. Elizabeth Le, MD, Bhaskar L. Arora, MBBS, Faith R. Kelly, MD, Stephen W. Waldo, MD, Merritt Raitt, MD, Paul Heidenreich, MD, MS, Samit M. Shah, MD, PhD, Ali E. Denktas, MD, Kreton O. Mavromatis, MD

    Published 2025-02-01
    “…A total of 9 million veterans receive care in a unique healthcare system, the Veterans Healthcare Administration (VHA), with nearly 50% reporting at least one cardiovascular disease. Despite evidence for high quality of health care in the VHA, more veteran care is being moved to the non-VHA community. …”
    Get full text
    Article
  3. 43
  4. 44
  5. 45
  6. 46
  7. 47

    Induced Pluripotent Stem Cells in Cardiovascular Medicine by Toru Egashira, Shinsuke Yuasa, Keiichi Fukuda

    Published 2011-01-01
    “…This paper summarizes the progress of iPS cell technology in cardiovascular research.…”
    Get full text
    Article
  8. 48

    Cardiovascular and Renal Links along the Cardiorenal Continuum by José A. García-Donaire, Luis M. Ruilope

    Published 2011-01-01
    “…The cardiorenal syndrome includes the widely known relationship between kidney function and cardiovascular disease. A large number of patients have various degrees of heart and kidney dysfunction worldwide, both in developed and developing countries. …”
    Get full text
    Article
  9. 49

    Genetic Markers of Cardiovascular Disease in Rheumatoid Arthritis by Luis Rodríguez-Rodríguez, Raquel López-Mejías, Mercedes García-Bermúdez, Carlos González-Juanatey, Miguel A. González-Gay, Javier Martín

    Published 2012-01-01
    “…Cardiovascular (CV) disease is the most common cause of premature mortality in patients with rheumatoid arthritis (RA). …”
    Get full text
    Article
  10. 50

    Malformaciones congénitas cardiovasculares. Cienfuegos, 2008-2017 by Maylé Santos Solís, Vivian Rosa Vázquez Martínez, Oramis Isabel Padrón Aguilera, Cristóbal Jorge Torres González., Daniela Beatriz Aguiar Santos

    Published 2020-04-01
    “…<p><strong>Fundamento</strong>: Las malformaciones congénitas cardiovasculares contribuyen de forma importante a la mortalidad infantil, por lo que el estudio de su comportamiento resulta de interés.…”
    Get full text
    Article
  11. 51
  12. 52
  13. 53

    Multimodality Imaging in the Evaluation of Cardiovascular Manifestations of Malignancy by Laura Jiménez-Juan, Jessica Leen, Rachel M. Wald, Elsie T. Nguyen, Andrew T. Yan, Anish Kirpalani, Bernd J. Wintersperger, Andrew M. Crean

    Published 2011-01-01
    “…The purpose of this article is to review not only some of the commoner cardiovascular manifestations of malignancy but also to discuss the strengths, weaknesses and appropriate use of cardiovascular imaging modalities.…”
    Get full text
    Article
  14. 54

    Stress in Obesity and Associated Metabolic and Cardiovascular Disorders by Paul Holvoet

    Published 2012-01-01
    “…It is associated with high atherosclerotic cardiovascular risk, which can only partially be explained by its components. …”
    Get full text
    Article
  15. 55

    Exposure to particulate matter and cardiovascular disease risk by Grażyna Nowicka

    Published 2007-12-01
    “…Epidemiological studies clearly indicate that both long- and short-term exposure to several environmental air pollutants cause significant increase in the risk of cardiovascular events, the observed strong relation between particulate matter air level and cardiovascular diseases may be explained by indirect or direct influence of these particles on different biological processes involved in disease development. …”
    Get full text
    Article
  16. 56
  17. 57
  18. 58
  19. 59
  20. 60

    PPAR Genomics and Pharmacogenomics: Implications for Cardiovascular Disease by Sharon Cresci

    Published 2008-01-01
    “…The peroxisome proliferator-activated receptors (PPARs) consist of three related transcription factors that serve to regulate a number of cellular processes that are central to cardiovascular health and disease. Numerous pharmacologic studies have assessed the effects of specific PPAR agonists in clinical trials and have provided insight into the clinical effects of these genes while genetic studies have demonstrated clinical associations between PPAR polymorphisms and abnormal cardiovascular phenotypes. …”
    Get full text
    Article